Get the Stockscreener App
41.11
7.48%
2.86
Moderna Inc stock is traded at $41.11, with a volume of 13.30M.
It is up +7.48% in the last 24 hours and down -23.01% over the past month.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
See More
Previous Close:
$38.25
Open:
$38.44
24h Volume:
13.30M
Relative Volume:
2.04
Market Cap:
$15.82B
Revenue:
$5.06B
Net Income/Loss:
$-2.22B
P/E Ratio:
-4.3968
EPS:
-9.35
Net Cash Flow:
$-3.96B
1W Performance:
+11.56%
1M Performance:
-23.01%
6M Performance:
-74.83%
1Y Performance:
-47.41%
1-Day Range:
$37.76
$42.40
1-Week Range:
$35.96
$42.40
52-Week Range:
$35.80
$170.47
Moderna Inc Stock (MRNA) Company Profile
Name
Moderna Inc
Sector
Industry
Phone
(617) 714-6500
Address
325 BINNEY STREET, CAMBRIDGE
Compare MRNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| MRNA | 41.11 | 15.82B | 5.06B | -2.22B | -3.96B | -9.35 |
| VRTX | 450.97 | 116.38B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 738.00 | 82.09B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 605.92 | 36.14B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 113.13 | 27.25B | 3.30B | -501.07M | 1.03B | 11.54 |
Moderna Inc Stock (MRNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-13-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-13-24 | Downgrade | Jefferies | Buy → Hold |
| Sep-13-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-28-24 | Upgrade | HSBC Securities | Reduce → Hold |
| Aug-07-24 | Upgrade | Deutsche Bank | Sell → Hold |
| Aug-05-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-26-24 | Downgrade | HSBC Securities | Hold → Reduce |
| Jan-02-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-29-23 | Initiated | Canaccord Genuity | Hold |
| Nov-03-23 | Upgrade | HSBC Securities | Reduce → Hold |
| Nov-02-23 | Downgrade | Deutsche Bank | Hold → Sell |
| Aug-04-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Aug-03-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-24-23 | Initiated | William Blair | Mkt Perform |
| Jul-14-23 | Initiated | HSBC Securities | Reduce |
| Jun-26-23 | Upgrade | UBS | Neutral → Buy |
| Apr-26-23 | Initiated | Guggenheim | Neutral |
| Mar-13-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Mar-02-23 | Initiated | RBC Capital Mkts | Outperform |
| Feb-24-23 | Downgrade | SVB Securities | Market Perform → Underperform |
| Dec-19-22 | Upgrade | Jefferies | Hold → Buy |
| Dec-14-22 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Oct-21-22 | Upgrade | SVB Leerink | Underperform → Mkt Perform |
| Sep-08-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-01-22 | Upgrade | Redburn | Sell → Neutral |
| Jan-26-22 | Upgrade | Deutsche Bank | Sell → Hold |
| Jan-21-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-21-22 | Initiated | UBS | Neutral |
| Dec-07-21 | Initiated | Cowen | Market Perform |
| Nov-09-21 | Initiated | Wolfe Research | Outperform |
| Oct-22-21 | Initiated | Deutsche Bank | Sell |
| Oct-15-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-06-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-06-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-15-21 | Reiterated | Jefferies | Hold |
| Feb-01-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-16-20 | Downgrade | Jefferies | Buy → Hold |
| Dec-16-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-09-20 | Downgrade | Needham | Buy → Hold |
| Nov-23-20 | Initiated | Wells Fargo | Equal Weight |
| Nov-17-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-08-20 | Downgrade | SVB Leerink | Mkt Perform → Underperform |
| Jul-23-20 | Initiated | SVB Leerink | Mkt Perform |
| Jul-20-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-13-20 | Initiated | Jefferies | Buy |
| Jun-30-20 | Initiated | Argus | Buy |
| Jun-08-20 | Initiated | Barclays | Overweight |
| Apr-30-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Dec-03-19 | Resumed | BofA/Merrill | Buy |
| Oct-25-19 | Initiated | ROTH Capital | Buy |
| Apr-05-19 | Initiated | Chardan Capital Markets | Buy |
View All
Moderna Inc Stock (MRNA) Latest News
Moderna Stock Soars After Strong Sales Forecast - Evrim Ağacı
Jefferies says market nears short term “peak RFK negativity", Vaccine makers up - MSN
תאריך היעד לתביעה נגד MGX ביום שני: רוזן, משרד עורכי דין מהשורה הראשונה, מעודד את המשקיעים ב- Metagenomi, Inc לקבל ייעוץ לפני תאריך יעד חשוב של 25 בנובמבר בתביעה ייצוגית בניירות ערך – MGX - GlobeNewswire Inc.
Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference - MSN
Goldman Sachs: Moderna, Inc. (NASDAQ:MRNA) Is A Top Growth Investor Stock - Yahoo Finance
Moderna, Gap pop, Tesla drives higher - Yahoo Finance
Jefferies holds Moderna at $50 target, cites RFK concerns - Investing.com
Moderna up 8% as Jefferies says market is close to 'peak RFK negativity' - Seeking Alpha
Moderna's Fresh Blow As RFK Heads To HHSA Tough 2025 May Be In Store (NASDAQ:MRNA) - Seeking Alpha
Banco Santander S.A. Takes Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Shareholders of Moderna, Inc. Should Contact The Gross Law Firm - GuruFocus.com
Why Is Moderna, Inc. (MRNA) Among the Worst Performing Biotech Stocks in 2024? - Insider Monkey
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
Moderna Inc. stock outperforms competitors on strong trading day - MarketWatch
Moderna, Inc. (NASDAQ:MRNA) Shares Purchased by John G Ullman & Associates Inc. - MarketBeat
Moderna Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
US CDC expects COVID and RSV levels to increase in coming weeks - Marketscreener.com
FY2025 EPS Estimates for Moderna Decreased by Analyst - MarketBeat
Moderna Stock Rises on Q3 Earnings & Sales Beat, Reiterates View - MSN
Moderna initiated with a Hold at Berenberg - Yahoo Finance
Moderna's stock decline after RFK Jr's appointment makes an "attractive entry point": Piper Sandler - MSN
Moderna Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
BioNTech started at buy, Moderna at hold by Berenberg (NASDAQ:BNTX) - Seeking Alpha
Today's Top Stocks: HSIC, Moderna, Uber and More - Baystreet.ca
Berenberg Bank Initiates Coverage on Moderna (NASDAQ:MRNA) - MarketBeat
Hsbc Global Res Upgrades Moderna (NASDAQ:MRNA) to Strong-Buy - MarketBeat
HSBC upgrades Moderna to Buy on pipeline potential - Yahoo Finance
BioNTech and Moderna at vanguard of new treatment wavebut which is best? - Proactive Investors UK
MODERNA : Berenberg sticks Neutral - Marketscreener.com
Health Care Flat After Last Week's SelloffHealth Care Roundup - Marketscreener.com
Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination - AOL
10 Biggest Biotechnology Companies - Investopedia
Moderna (NASDAQ:MRNA) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Moderna (NASDAQ:MRNA) Receives "Overweight" Rating from Piper Sandler - MarketBeat
Moderna (NASDAQ:MRNA) Raised to Buy at HSBC - MarketBeat
Analyst recommendations: Biogen, HP, Moderna, Shell... - Marketscreener.com
KBC Group NV Cuts Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Wolfe Research Initiates Coverage of Moderna (MRNA) with Underperform Recommendation - MSN
Health Care Down as RFK Fears Mount -- Health Care Roundup - Marketscreener.com
Moderna Inc. stock underperforms Friday when compared to competitors - MarketWatch
Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS - Yahoo! Voices
Moderna, Pfizer pharma stock dips after RFK Jr. nominated to lead HHS - Healthcare Brew
Moderna Shares Are Dipping Today: What's Going On? - Benzinga
Health stocks are tumbling after Trump's appointment of vaccine skeptic RFK Jr. - Markets Insider
Moderna (NASDAQ:MRNA) Shares Gap DownTime to Sell? - MarketBeat
Moderna, Inc. (MRNA): Among 12 High Growth Large Cap Stocks to Buy Now - Yahoo Finance
First Week of July 2025 Options Trading For Moderna (MRNA) - Nasdaq
Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
RFK Jr vow to purge FDA sets up collision with Big Pharma - Reuters.com
Moderna continues to be the most shorted among S&P 500 healthcare stocks in October - Seeking Alpha
Moderna Inc Stock (MRNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
2.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):